QuidelOrtho (QDEL) - 2024 Q1 - Earnings Call Presentation

© 2024. All Rights Reserved. 3 (76%) y/y3 Q1 2024 Highlights1Total Revenue $711M (16 %) y/y1 Global year-over-year revenue growth 2 3 across regions of 5% as reported and 6% in constant currency ("CC"), excluding COVID-19 revenue Adjusted EBITDA$ 132M 19% Margin2 Adjusted Diluted EPS $0.44 • Excluding the one-time thirdparty collaboration settlement in Q1'23, non-respiratory revenue grew 3% as reported and 4% in CC • Excluding government COVID19 orders, respiratory revenue grew 6% as reported and in CC © 20 ...